At KaRa MINDS, we collaborate with international partners to prevent conditions such as Alzheimer's disease through research.
You may be eligible to take part in the many clinical trials we run at our Institute.
ENGAGE Study
Recruitment closed
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer’s Disease
Mission AD
Recruiting Mild Cognitive Impairment and Alzheimer’s disease
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects with Early Alzheimer’s Disease
XanADu Study
Recruitment closed
A Phase II, Double -Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of XanamemTM in Subjects with Mild Dementia due to Alzheimer’s Disease(AD)
ICURE Study
Recruiting – Early to Moderate Alzheimer’s disease
A multinational, multi-center, randomized, double-blind, active comparator, phase III clinical trial to evaluate the efficacy and safety of donepezil transdermal patch in patients with Alzheimer’s disease
Retinal Study
Recruiting - limited access study requirements
Investigating the diagnostic utility of hyperspectral retinal imaging in preclinical Alzheimer’s disease
ANAVEX Study
Recruitment open
A Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy trial of ANAVEX2-73 for the Treatment of Early Alzheimer’s Disease (AD)
Total Study
Recruitment via Macquarie University (Healthy Males)
A 56 week, Double-Blind, Randomised Study to Evaluate the Efficacy of Testosterone, With and Without DHA Supplementation on Cerebral Amyloid Load in Known Brain Amyloid-PET Positive Men with Subjective Memory Complaints
KARVIAH Study
Ongoing investigational study (Healthy participants)
For further details on any study, please call KaRa MINDS or use the Contact Us form at the bottom of the page and our friendly team will be in touch.
